Advicenne S.A. reported sales results for the year 2022. For the period, the company reports sales of 3.7 million, up 13% compared to the previous year (2021: 3.3 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 EUR | +9.62% | +18.17% | -20.30% |
Apr. 08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 25 | Advicenne: ODD designation in cystinuria | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.30% | 28.31M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- ALDVI Stock
- News Advicenne
- Advicenne S.A. Reports Sales Results for the Year 2022